Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
January 31, 2022 Cover
Volume 100, Issue 4
100 years after insulin was first used to treat type 1 diabetes, researchers are still finding ways to improve it
Cover image:100 years after insulin was first used to treat type 1 diabetes, researchers are still finding ways to improve it
Credit: Will Ludwig/C&EN/University of Toronto/Shutterstock
Insulin’s second century
100 years after insulin was first used to treat type 1 diabetes, researchers are still finding ways to improve it
The many ways to inhibit PCSK9
Companies are exploring multiple drug types to target the heart disease–linked protein
Thomas Maschmeyer is building batteries fit for the Australian outback
His start-up, Gelion, wants to bring zinc bromide batteries—and more-reliable power—to remote regions
-
Periodic Graphics: A short history of antiviral drugs
Chemical educator and Compound Interest blogger Andy Brunning lists some notable compounds that target viruses.
-
COVID-19 lockdowns prevented pollution-related deaths
Lower emissions during European lockdowns in 2020 could suggest how to improve health in cities longer term
-
Pittcon 2022 is canceled because of COVID-19
As organizers look at a replacement virtual format, other conferences are going ahead in person
ADVERTISEMENT
Science Concentrates
Business & Policy Concentrates
EDITORIAL
AWARDS
- 2022 Cope and Cope Scholar Award winners
- Jacqueline K. Barton to receive 2021 Theodore Richards Award for conspicuous achievement in chemistry
- Green chemistry grants totaling $300,000 awarded by ACS GCI Pharma Roundtable in 2021
- HIST announces recipients of 2021 Citation for Chemical Breakthrough Awards
